Teva Pharmaceutical Industries Ltd (TEVA :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
TEVA FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
UPDATE 1-Judge denies FDA bid to stay 'morning-after' pill ruling 10 May 2013 - Reuters
-
Lightning Round: SunTrust, Nokia & More 09 May 2013 - CNBC.com
-
-
Lightning Round: Hertz, US Airways & More 08 May 2013 - CNBC.com
-
Judge criticizes FDA move on Plan B, agency warns of precedent 07 May 2013 - Reuters
-
Teva CEO sees Q1 2014 FDA action on 3-times-a-week Copaxone 02 May 2013 - AFX
-
UPDATE 1-U.S. FDA appeals making 'morning-after' pill available to all... 01 May 2013 - Reuters
-
FDA files appeal over 'morning-after' pill decision 01 May 2013 - Reuters
-
Drugs from Amgen, others assessed by FDA as radiation treatments 01 May 2013 - AFX
MORE FROM CNBC
-
Lightning Round: SunTrust, Nokia & More 09 May 2013 - CNBC.com
-
-
Lightning Round: Hertz, US Airways & More 08 May 2013 - CNBC.com
-
Fed May Provide a Safety Net for the Market 26 Apr 2013 - CNBC.com
MORE FROM OUR PARTNERS
-
Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry 20 hrs ago - Seeking Alpha
LATEST TRANSCRIPTS
-
Teva Pharmaceutical's CEO Discusses Q1 2013 Results - Earnings Call Tr... 02 May 2013 - Seeking Alpha
PRESS RELEASES
-
Antares Pharma Welcomes Marvin Samson to Board of Directors 2 hrs ago - Business Wire
-
OncoGenex Announces Plans for the Initiation of the Cedar(TM) Clinical... 2 hrs ago - PR Newswire
-
Ambit Biosciences Announces Presentations of Data from Clinical Invest... 22 May 2013 - PR Newswire
-
OncoGenex Announces Multiple 'Trials in Progress' Presentations at the... 22 May 2013 - PR Newswire
-
Ambit Biosciences Announces Pricing of Initial Public Offering 16 May 2013 - PR Newswire
-
Synthetic Biologics Reports First Quarter 2013 Financial Results 15 May 2013 - PR Newswire
-
Alexza Reports 2013 First Quarter Financial Results 14 May 2013 - PR Newswire
-
Teva to Present at the Bank of America Merrill Lynch 2013 Health Care ... 14 May 2013 - Business Wire
-
BioTime's Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million... 13 May 2013 - Business Wire
-
Antares Pharma to Present at the Bank of America Merrill Lynch 2013 He... 09 May 2013 - Business Wire
